Literature DB >> 34987737

Virtual Crossmatching in Kidney Transplantation, Shiraz Experience in Development of a Web-Based Program.

N Jamshidian Tehrani1, B Geramizadeh1, S A Malekhosseini1, S Nikeghbalian1, A Bahador1, S Gholami1, G A Raees Jalali1, J Roozbeh1,2, M H Anbardar1, N Soleimani1, N Rasaei1, S Mohammadzadeh1.   

Abstract

BACKGROUND: Kidney transplantation can increase survival and quality of life in patients with end-stage renal disease. In any allocation system, the crossmatch test plays an essential role in donor-recipient compatibility.
OBJECTIVE: In this study, we aim to test the benefits of a web-based program that captures HLA antibody analyses and provides a report to allow fast and accurate virtual crossmatches.
METHODS: One hundred potential recipients in the waiting list of renal transplants were selected. The included patients all had a complete HLA antibody profile. Also, 10 potential donors from previous kidney transplants (2020), with available HLA typing results for A, B, and DR locus, were also selected. A comparison was made between 100 recipients against ten potential donors, and virtual crossmatching (VXM) was performed by the web-based program and manually by an experienced immunologist.
RESULTS: The average time for a manual VXM was 30 minutes per patient, while the virtual cross web-based program took 5 minutes per patient. In 12% of the manual VXM cases, a secondary review of data improved final results. In two manual virtual crossmatches, the VXM results had errors in matching recipient antibodies with the donor HLA typing that could affect the final decision for transplantation.
CONCLUSION: In conclusion, a web-based VXM program that assesses HLA data can accurately perform a VXM with fewer human errors. It is especially true for highly sensitized candidates.

Entities:  

Keywords:  HLA; Kidney transplantation; Virtual crossmatch

Year:  2021        PMID: 34987737      PMCID: PMC8717962     

Source DB:  PubMed          Journal:  Int J Organ Transplant Med        ISSN: 2008-6482


  28 in total

1.  Histoimmunogenetics Markup Language 1.0: Reporting next generation sequencing-based HLA and KIR genotyping.

Authors:  Robert P Milius; Michael Heuer; Daniel Valiga; Kathryn J Doroschak; Caleb J Kennedy; Yung-Tsi Bolon; Joel Schneider; Jane Pollack; Hwa Ran Kim; Nezih Cereb; Jill A Hollenbach; Steven J Mack; Martin Maiers
Journal:  Hum Immunol       Date:  2015-08-28       Impact factor: 2.850

2.  HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors.

Authors:  D Sayer; R Whidborne; B Brestovac; F Trimboli; C Witt; F Christiansen
Journal:  Tissue Antigens       Date:  2001-01

3.  Luminex-based virtual crossmatching for renal transplantation in South Africa.

Authors:  Catherine M Worsley; Elizabeth S Mayne; Melinda S Suchard
Journal:  S Afr Med J       Date:  2011-12-14

Review 4.  Paired kidney donations to expand the living donor pool: the Western Australian experience.

Authors:  Paolo Ferrari; Claudia Woodroffe; Frank T Christiansen
Journal:  Med J Aust       Date:  2009-06-15       Impact factor: 7.738

Review 5.  Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications.

Authors:  R J Duquesnoy
Journal:  Tissue Antigens       Date:  2011-03-17

6.  OPO Strategies to Prevent Unintended Use of Kidneys Exported for High PRA (>98% cPRA) Recipients.

Authors:  A S Paramesh; N Neidlinger; M Salvatore; A Smith; A Friedman; W Payne; T Taber; C Wright
Journal:  Am J Transplant       Date:  2017-03-03       Impact factor: 8.086

7.  Pretransplant risk assessment in renal allograft recipients using virtual crossmatching.

Authors:  D Bielmann; G Hönger; D Lutz; M J Mihatsch; J Steiger; S Schaub
Journal:  Am J Transplant       Date:  2007-03       Impact factor: 8.086

8.  Paired kidney donations to expand the living donor pool.

Authors:  Paolo Ferrari; Marry de Klerk
Journal:  J Nephrol       Date:  2009 Nov-Dec       Impact factor: 3.902

9.  (F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch.

Authors:  Harold C Sullivan; Christina L Dean; Robert S Liwski; Shilpee Biswas; Abigail L Goodman; Scott Krummey; Howard M Gebel; Robert A Bray
Journal:  Hum Immunol       Date:  2018-08-03       Impact factor: 2.850

10.  Logistical Factors Influencing Cold Ischemia Times in Deceased Donor Kidney Transplants.

Authors:  Sussie Shrestha; Lisa Bradbury; Matthew Boal; James P Blackmur; Christopher J E Watson; Craig J Taylor; John L R Forsythe; Rachel Johnson; Lorna P Marson
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

View more
  1 in total

1.  Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival.

Authors:  Ion Mărunţelu; Claudiu Eduard Nistor; Bogdan Mihai Cristea; Corina Andreea Rotarescu; Andreea Mirela Caragea; Maria Tizu; Ileana Constantinescu
Journal:  Ann Transplant       Date:  2022-08-12       Impact factor: 1.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.